July 2000
Worldwide Biotech;Jul2000, Vol. 12 Issue 7, p4
Trade Publication
Reports that Roche and Gilead Sciences Inc. have announced the withdrawal of Roche in its European application for the antiviral Tamiflu for the treatment of influenza following questions by the Committee for Proprietary Medicinal Products.


Related Articles

  • New Drugs for Fighting Flu. Braun, Wendy A. // Medical Update;Dec98, Vol. 22 Issue 6, p2 

    Provides information on the drugs, Relenza and GS4104 product developed by Glaxo Wellcome Inc. and F. Hoffman-La Roche for the treatment of influenza. Complications of fever that can be prevented by GS4104; Classification of the drugs; Route of administration of the drugs.

  • Roche: Tamiflu sales hit by fading flu hype.  // PharmaWatch: Monthly Review;Mar2009, Vol. 8 Issue 3, p29 

    The article reports on the worldwide 2008 sales performance of Roche Pharmaceuticals's Tamiflu for the treatment of influenza. According to its 2008 annual results, its sales have decreased by 68% from CHF2.0 billion in 2007 to CHF609 million in 2008. It blames the waning attention of...

  • Watch for fake pills as Tamiflu supplies slow. Rillstone, Gerald // New Zealand Doctor; 

    Focuses on a warning issued by Stewart Jessamine, Medsafe medical advisor, on the possible advent of fake Tamiflu anti-influenza agent in relation to its decreasing supply as of November 2005. Reason for the decline in Tamiflu supply; Factors associated with the plan of Roche to limit supplies...

  • The Imperative to Share Clinical Study Reports: Recommendations from the Tamiflu Experience. Doshi, Peter; Jefferson, Tom; Mar, Chris Del // PLoS Medicine;Apr2012, Vol. 9 Issue 4, p1 

    The article provides information on the failure of influenza antiviral Tamiflu (oseltamnivir) to reduce complications. The U.S. Food and Drug Administration (FDA) mentioned that Tamiflu had been revealed to lessen complications and needed an explicit statement label of the drug to that effect....

  • Research questions £400m flu drug stockpile.  // GP: General Practitioner;4/14/2014, p44 

    The article discusses a study by the nonprofit organization Cochrane Collaboration, which indicates that the influenza drug oseltamivir (Tamiflu) does not reduce serious complications or hospital admissions from flu. Topics addressed include money wasted by the British government by stockpiling...

  • Drugs to prevent or shorten flu attacks?  // Consumers' Research Magazine;Nov97, Vol. 80 Issue 11, p40 

    Announces the development of Glaxo drug and Roche drug by Glaxo Wellcome and Roche Holding companies for the treatment of flu viruses. Uses of the drugs; Remarks of Doctor Frederick Hayden of the University of Virginia about the drugs.

  • Tamiflu Value Sparks Questions. Siew, Adeline // Pharmaceutical Technology Europe;May2014, Vol. 26 Issue 5, p6 

    The author reflects on the review of the article "Oseltamivir for influenza in adults and children: systematic review of clinical study reports and summary of regulatory comments" by Cochrane Collaboration, an independent organization that organizes medical research information. She mentions...

  • Avian flu threat puts pharmaceutical biz in heated crossfire. Mortensen, Jill // Media: Asia's Media & Marketing Newspaper;11/4/2005, p18 

    This article reports that the pharmaceutical industry must take a stance on a potential avian flu outbreak. Roche Holding AG, no stranger to the HIV/Aids debate, is on the frontline of the current issue. Experts have confirmed that Tamiflu, its antiviral brand commonly used to treat flu...

  • Europe Approves Child-Sized Anti-Flu Medicine.  // Drug Discovery & Development;Oct2007, Vol. 10 Issue 10, p32 

    The article reports that the European Commission has approved the child-sized capsules for anti-flu drug Tamiflu from Roche Pharmaceuticals. It is stated that the lower dose capsules of 30mg and 45mg provide an alternative for treating and preventing influenza types A and B in children one year...


Read the Article


Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics